Turbomed Orthotics
Turbomed Orthotics is a Quebec-based medical device company that designs and sells the patented XTERN external ankle foot orthosis for foot drop patients across stroke, MS, cerebral palsy, pediatric, and athletic segments, distributed via US insurance billing, 400+ clinics, and direct e-commerce.
- Company typePrivate
- Founded2015
- HeadquartersSaint-augustin, Canada
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Turbomed Orthotics does
Turbomed Orthotics is a privately held Canadian medical device company headquartered in St-Augustin-de-Desmaures, Quebec, that designs, manufactures, and distributes external ankle foot orthoses (AFOs) under the XTERN brand for patients suffering from foot drop and dorsiflexion weakness. Its core product is a patented external exoskeleton spring made from thermoplastic materials that laces onto the outside of footwear, providing dynamic dorsiflexion assistance while preserving full ankle range of motion, in contrast to conventional rigid AFOs that fit inside the shoe. The product family includes three adult models (XTERN CLASSIC+, XTERN SUMMIT, XTERN FRONTIER) with separate PDAC-validated HCPCS billing codes (L1951 and L1932), a pediatric variant, the AT-X clinical assessment tool, and a line of replacement parts and accessories (ankle straps, extension stopper kits, heel bumpers, lace-clips, velcro straps).
The company generates revenue primarily through one-time hardware sales priced at $945-$1,200 USD per orthosis, distributed via three channels: direct-to-consumer e-commerce on turbomedorthotics.com and turbomedusa.com (self-pay), the US distributor Physiotech which bills Medicare, Medicaid, VA, and private insurance, and a network of more than 400 orthotics & prosthetics clinics, DME stores, podiatrists, and physical therapy centers across the United States. Internationally, products are distributed in more than 20 countries and sold in more than 35, supported by CE Class I certification, Health Canada Medical Device Establishment License No. 6354, FDA Registration No. 3011816892, and granted patents in the US, Canada, and Europe. The company is owned 100% by co-founder Stéphane Savard with two family members, operates with 1-10 employees, has no disclosed institutional funding, and serves end customers across stroke, multiple sclerosis, cerebral palsy, Charcot-Marie-Tooth, peroneal nerve injury, Guillain-Barre, pediatric, and athletic foot drop populations.
Turbomed Orthotics firmographics
Firmographics- Name
- Turbomed Orthotics
- Legal name
- Turbomed Orthotics
- Website
- https://turbomedorthotics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Turbomed Orthotics is a Quebec-based medical device company that designs and sells the patented XTERN external ankle foot orthosis for foot drop patients across stroke, MS, cerebral palsy, pediatric, and athletic segments, distributed via US insurance billing, 400+ clinics, and direct e-commerce.
- Ownership category
- akta.pro rank
Turbomed Orthotics industry classification
Industry- Product category
- Ankle Foot Orthotics
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC)
- akta.pro secondary industry
- Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI)
Keywords
Where Turbomed Orthotics is headquartered
LocationHeadquarters
- HQ city
- Saint-augustin
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Turbomed Orthotics business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- AFO Hardware Sales: Primary revenue from selling external ankle foot orthosis devices directly to patients and through distributors. Products include XTERN CLASSIC+, XTERN SUMMIT, XTERN FRONTIER, and pediatric models. Revenue is one-time hardware purchase with optional replacement parts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | XTERN CLASSIC+ - Standard adult model with MonoCore technology |
| One time/ perpetual license | Pay-as-you-go | XTERN SUMMIT - Premium model |
| One time/ perpetual license | Pay-as-you-go | XTERN FRONTIER - Alternative model with HCPCS Code L1932 |
| One time/ perpetual license | Pay-as-you-go | XTERN PEDIATRIC - Child-specific model |
| One time/ perpetual license | Pay-as-you-go | AT-X Assessment Tool - Clinical evaluation/demo brace |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Turbomed Orthotics product offering
Product offeringCore offering
Turbomed Orthotics designs, manufactures, and distributes external ankle foot orthosis (AFO) devices under the XTERN brand for the treatment of foot drop and dorsiflexion weakness. The XTERN brace is a custom-built modular thermoplastic exoskeleton with a preloaded spring that attaches to the outside of footwear, allowing full ankle range of motion while controlling foot drop. The company also offers the AT-X clinical assessment tool and a range of replacement parts and accessories for the XTERN line.
Product overview
Turbomed Orthotics offers a family of external ankle foot orthoses (AFOs) sold under the XTERN brand, designed to address foot drop and dorsiflexion weakness. The core product line consists of three adult AFO models (XTERN CLASSIC+, XTERN SUMMIT, and XTERN FRONTIER), plus a pediatric version. All XTERN AFOs share a common modular thermoplastic design with an exoskeleton spring mechanism that attaches externally to footwear, controlling foot drop while preserving natural ankle range of motion and calf muscle function. The portfolio also includes the AT-X Assessment Tool for clinical trials, and a range of replacement parts and accessories (ankle straps, extension stopper kits, heel bumper kits, lace-clips, and velcro replacement straps) that support the ongoing use and customization of the orthoses. The products are distributed directly, through US clinics (400+ locations), and via the online store, with insurance/Medicare coverage supported by PDAC-validated HCPCS codes.
Differentiator
Problem solved
Functional benefit
Brands
- XTERN: External ankle foot orthosis (AFO) product line for foot drop treatment, including XTERN CLASSIC+, XTERN FRONTIER, and XTERN SUMMIT models.
- AT-X
Quantifiable outcome
- More than 75% of customers will regain normal use of their legs in a short time
- +2 more outcomes
Companies that use Turbomed Orthotics
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles3 records
Turbomed Orthotics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Turbomed Orthotics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PhysiotechcorePhysiotech is the primary US-based distributor for TurboMed products. They accept private insurance, Medicare, Medicaid, and VA benefits, making XTERN accessible to patients with insurance coverage. Physiotech assembles customized XTERN braces and provides them directly to patients ready to use. They also provide insurance verification tools on footdropbrace.com.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Turbomed Orthotics competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights7 records
Customer concentration
Turbomed Orthotics social profiles
Digital presenceTurbomed Orthotics compliance and trust
Trust signalCompliance5 records
Turbomed Orthotics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Turbomed Orthotics leadership team
Management profileNumber of profiles
Profiles2 records
Turbomed Orthotics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Turbomed Orthotics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Turbomed Orthotics
What does Turbomed Orthotics do?
Turbomed Orthotics designs, manufactures, and distributes external ankle foot orthosis (AFO) devices under the XTERN brand for the treatment of foot drop and dorsiflexion weakness. The XTERN brace is a custom-built modular thermoplastic exoskeleton with a preloaded spring that attaches to the outside of footwear, allowing full ankle range of motion while controlling foot drop. The company also offers the AT-X clinical assessment tool and a range of replacement parts and accessories for the XTERN line.
Is Turbomed Orthotics a public or private company?
Turbomed Orthotics is a private company. It is classified as family owned and is currently operating.
When was Turbomed Orthotics founded?
Turbomed Orthotics was founded in 2015. It employs 1 to 10 people.
Where is Turbomed Orthotics based?
Turbomed Orthotics is headquartered in Saint-augustin, Canada, in the North America region.
How does Turbomed Orthotics make money?
One revenue line is on record: AFO Hardware Sales.
Does Turbomed Orthotics have an API?
No public API is recorded for Turbomed Orthotics.
What industry is Turbomed Orthotics in?
Turbomed Orthotics's product category is Ankle Foot Orthotics. Its primary akta.pro industry code is HLAHAMAC, Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports), with a secondary code of HLAHAEAI, Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses). Its SIC code is 3842.